Elsevier

Pathology

Volume 43, Issue 5, August 2011, Pages 420-432
Pathology

Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis

https://doi.org/10.1097/PAT.0b013e328348a6e7Get rights and content

Summary

Ovarian carcinomas comprise a heterogeneous group of neoplasms, the four most common subtypes being serous, endometrioid, clear cell and mucinous. In recent years, our understanding of the underlying pathogenesis and initiating molecular events in the different tumour subtypes has greatly increased, and although ovarian carcinoma is often considered clinically as one disease, there is now a much greater realisation that the various subtypes have a different natural behaviour and prognosis. At present, adjuvant therapy is mainly dependent upon tumour stage and grade rather than type; however, this is likely to change in the future with the development of new chemotherapeutic agents and targeted therapies and clinical trials are necessary to evaluate the efficacy of different agents in clear cell, mucinous and low grade serous carcinomas, neoplasms which are considered relatively resistant to traditional chemotherapeutic regimes. In this review, the major subtypes of ovarian carcinoma are discussed. It is now firmly established that there are two distinct types of ovarian serous carcinoma, low grade and high grade, the former being much less common and arising in many cases from a serous borderline tumour. Low grade and high grade serous carcinoma represent two distinct tumour types with a different underlying pathogenesis rather than low grade and high grade variants of the same neoplasm. Both are usually advanced stage (stage III or IV) at diagnosis. B-raf and k-ras mutations are important molecular events in low grade serous carcinomas while high grade serous carcinomas are almost always associated with TP53 mutation. There is now emerging and compelling evidence that many high grade serous carcinomas (by far the most common subtype of ovarian carcinoma) actually arise from the epithelium of the distal fallopian tube. Future studies regarding the initiating molecular events in the development of this aggressive neoplasm should concentrate on this site. Primary ovarian mucinous carcinomas are uncommon, almost always unilateral and stage I, and largely of so-called intestinal or enteric type. Most arise in a stepwise manner from a pre-existing mucinous cystadenoma and mucinous borderline tumour. Endometrioid and clear cell carcinomas typically present as low stage neoplasms and in many, or most, cases arise from endometriosis; the former are usually well differentiated and there is now evidence that the majority of neoplasms reported in the past as high grade endometrioid carcinoma are of serous type. WT1 is useful in this regard since it is a relatively specific marker of a serous phenotype. It is recommended that different subtypes of ovarian carcinoma are graded using different systems rather than employing a universal grading system.

References (100)

  • R.J. Zaino

    Synchronous carcinomas of the uterine corpus and ovary

    Gynecol Oncol

    (1984)
  • L. Catasus et al.

    Molecular genetic alterations in endometrioid carcinomas of the ovary: similar frequency of beta-catenin abnormalities but lower rate of microsatellite instability and PTEN alterations than in uterine endometrioid carcinomas

    Hum Pathol

    (2004)
  • E.G. Silva et al.

    Undifferentiated carcinoma of the endometrium: a review

    Pathology

    (2007)
  • S. Yamamoto et al.

    Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium

    Hum Pathol

    (2007)
  • W.G. McCluggage

    My approach to and thoughts on typing of ovarian carcinomas

    J Clin Pathol

    (2008)
  • C.B. Gilks

    Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data

    Int J Gynecol Pathol

    (2004)
  • R.A. Soslow

    Histologic subtypes of ovarian carcinoma: an overview

    Int J Gynecol Pathol

    (2008)
  • H. Nomura et al.

    Lymph node metastasis in grossly apparent stages I and II epithelial ovarian cancer

    Int J Gynecol Cancer

    (2010)
  • J.D. Seidman et al.

    The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin

    Int J Gynecol Pathol

    (2004)
  • M. Kobel et al.

    Differences in tumor type in low-stage versus high-stage ovarian carcinomas

    Int J Gynecol Pathol

    (2010)
  • P.P. Koonings et al.

    Relative frequency of primary ovarian neoplasms: a ten year review

    Obstet Gynecol

    (1989)
  • K. Bertelsen et al.

    Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancer

    Int J Gynecol Cancer

    (1993)
  • J.P. Baak et al.

    Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing

    Anal Quant Cytol Histol

    (1986)
  • S.F. Cramer et al.

    Evaluation of the reproducibility of the World Health Organization classification of common ovarian cancers. With emphasis on methodology

    Arch Pathol Lab Med

    (1987)
  • B. Lund et al.

    Reproducibility of histopathological evaluation in epithelial ovarian carcinoma. Clinical implications

    APMIS

    (1991)
  • A. Sakamoto et al.

    Observer disagreement in histological classification of ovarian tumors in Japan

    Gynecol Oncol

    (1996)
  • W.G. McCluggage et al.

    Morphological effects of chemotherapy on ovarian carcinoma

    J Clin Pathol

    (2002)
  • K. Miller et al.

    An immunohistochemical and morphological analysis of post-chemotherapy ovarian carcinoma

    J Clin Pathol

    (2008)
  • S.G. Silverberg

    Histopathologic grading of ovarian carcinoma: a review and proposal

    Int J Gynecol Pathol

    (2000)
  • Y. Shimizu et al.

    Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proponed system in a series of 461 patients with uniform treatment and follow-up

    Cancer

    (1998)
  • N. Wilkinson et al.
  • H.E. Russell et al.

    A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes

    J Pathol

    (2004)
  • G. Singer et al.

    Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma

    Int J Gynecol Pathol

    (2003)
  • G. Singer et al.

    Patterns of p53 mutations separate ovarian serous borderline tumors and low and high grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation

    Am J Surg Pathol

    (2005)
  • C-L. Ho et al.

    Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors

    Can Res

    (2004)
  • N.L.G. Sieben et al.

    In ovarian neoplasms, BRAF, but not KRAS, mutation are restricted to low-grade serous tumours

    J Pathol

    (2004)
  • R. Vang et al.

    Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular bio-logic features, and diagnostic problems

    Adv Anat Pathol

    (2009)
  • W.G. McCluggage

    The pathology of and controversial aspects of ovarian borderline tumours

    Curr Opin Oncol

    (2010)
  • J.D. Seidman et al.

    Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases

    Am J Surg Pathol

    (1996)
  • D.W. Kindelberger et al.

    Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship

    Am J Surg Pathol

    (2007)
  • Y. Lee et al.

    Advances in the recognition of tubal intraepithelial carcinoma: applications to cancer screening and the pathogenesis of ovarian cancer

    Adv Anat Pathol

    (2006)
  • F. Medeiros et al.

    The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome

    Am J Surg Pathol

    (2007)
  • C.G. Przybycin et al.

    Are all pelvic (nonuterine) serous carcinomas of tubal origin?

    Am J Surg Pathol

    (2010)
  • Y. Lee et al.

    A candidate precursor to serous carcinoma that originates in the distal fallopian tube

    J Pathol

    (2007)
  • C.S. Herrington et al.

    The emerging role of the distal fallopian tube and p53 in pelvic serous carcinogenesis

    J Pathol

    (2010)
  • A. Malpica et al.

    Grading ovarian serous carcinoma using a two-tier system

    Am J Surg Pathol

    (2004)
  • A. Malpica et al.

    Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma

    Am J Surg Pathol

    (2007)
  • R. Dehari et al.

    The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis

    Am J Surg Pathol

    (2007)
  • E.G. Silva et al.

    Patterns of low-grade serous carci-noma with emphasis on the nonepitheliallined spaces pattern of invasion and the disorganised orphan papillae

    Int J Gynecol Pathol

    (2010)
  • Cited by (388)

    View all citing articles on Scopus
    View full text